A Santhera anuncia hoje a expans\u00e3o de seu acordo de distribui\u00e7\u00e3o exclusiva com a Biomedica para o AGAMREE (vamorolona), estendendo a parceria para incluir Ge\u00f3rgia, Cazaquist\u00e3o, Bielorr\u00fassia, Azerbaij\u00e3o e Uzbequist\u00e3o, para o tratamento da distrofia muscular de Duchenne (DMD) em pacientes com dois anos de idade ou mais.<\/p>\n\n\n\n
A Biomedica foi originalmente nomeada distribuidora do AGAMREE\u00ae em outubro de 2025. Com o acordo ampliado, a Biomedica ser\u00e1 respons\u00e1vel pela distribui\u00e7\u00e3o nos cinco mercados adicionais, enquanto a Santhera continuar\u00e1 recebendo uma porcentagem das vendas l\u00edquidas, conforme os termos do acordo original. Aproximadamente 2.000 pacientes vivem com DMD nesses pa\u00edses adicionais, onde as op\u00e7\u00f5es de tratamento historicamente se limitavam, em grande parte, aos corticosteroides convencionais. O acordo ampliado cria um caminho para disponibilizar o AGAMREE\u00ae a esses pacientes. Leia mais: O que \u00e9 AGAMREE (Vamorolone)?<\/a><\/p>\n\n\n\n <\/p>","protected":false},"excerpt":{"rendered":" Santhera today announces an expansion of its exclusive distribution agreement with Biomedica for AGAMREE (vamorolone), extending the partnership to include Georgia, Kazakhstan, Belarus, Azerbaijan and Uzbekistan, for the treatment of Duchenne muscular dystrophy (DMD) in patients two years of age and older. Biomedica was originally appointed as a distributor for AGAMREE\u00ae in October 2025. Under […]<\/p>\n","protected":false},"author":1,"featured_media":8252,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[281],"tags":[42,846,845,433,843,844,41,43],"class_list":["post-8251","post","type-post","status-publish","format-standard","has-post-thumbnail","category-press-releases","tag-agamree","tag-azerbaijan","tag-belarus","tag-biomedica","tag-georgia","tag-kazakhstan","tag-santhera","tag-vamorolone"],"_links":{"self":[{"href":"https:\/\/dmdwarrior.com\/pt\/wp-json\/wp\/v2\/posts\/8251","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dmdwarrior.com\/pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dmdwarrior.com\/pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/pt\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/pt\/wp-json\/wp\/v2\/comments?post=8251"}],"version-history":[{"count":1,"href":"https:\/\/dmdwarrior.com\/pt\/wp-json\/wp\/v2\/posts\/8251\/revisions"}],"predecessor-version":[{"id":8253,"href":"https:\/\/dmdwarrior.com\/pt\/wp-json\/wp\/v2\/posts\/8251\/revisions\/8253"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/pt\/wp-json\/wp\/v2\/media\/8252"}],"wp:attachment":[{"href":"https:\/\/dmdwarrior.com\/pt\/wp-json\/wp\/v2\/media?parent=8251"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dmdwarrior.com\/pt\/wp-json\/wp\/v2\/categories?post=8251"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dmdwarrior.com\/pt\/wp-json\/wp\/v2\/tags?post=8251"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}